GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Solventum Corp (FRA:KB7) » Definitions » Research & Development

Solventum (FRA:KB7) Research & Development : €718 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Solventum Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Solventum's Research & Development for the three months ended in Dec. 2024 was €190 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 was €718 Mil.

Solventum Research & Development Historical Data

The historical data trend for Solventum's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solventum Research & Development Chart

Solventum Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
591.02 677.91 724.05 695.09 740.13

Solventum Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 174.23 179.40 178.37 170.29 190.05

Solventum Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €718 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solventum  (FRA:KB7) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Solventum Research & Development Related Terms

Thank you for viewing the detailed overview of Solventum's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Solventum Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Solventum Corp (FRA:KB7) » Definitions » Research & Development
Comparable Companies
HOLX ATR ALGN AVTR RGEN WST BAX COO TFX STVN ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
SOLV:USA SOLV:Mexico KB7:Germany
Address
2510 Conway Avenue East, 3M Center, Building 275-6W, Maplewood, MN, USA, 55144
Website
https://www.solventum.com/en-us/home
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.

Solventum Headlines

No Headlines